TheraRadar
← Back
Data updated: Jun 28, 2026

STERINOVA INC

Generics
Pharmaceuticals

STERINOVA INC is a generic drug manufacturer with 1 FDA-approved products.

2025
Since
1
Drugs
-
Trials
0
New Drugs (2yr)

STERINOVA INC's Key Drugs

STERINOVA INC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

STERINOVA INC's Recent FDA Approvals

New NDA/BLA approvals for STERINOVA INC over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

STERINOVA INC's Therapeutic Areas

Disease areas where STERINOVA INC has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

STERINOVA INC Pipeline Snapshot

Active clinical trials for STERINOVA INC across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling